AI Science Tracker
EN

Identification and Validation of IFI44 as a Novel Biomarker for Primary Sjögren's Syndrome

First Teaching Hospital of Tianjin University of Traditional Chinese Medicine; National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion · 28 Aug 2024 · medicine

Discovery

Identification and Validation of IFI44 as a Novel Biomarker for Primary Sjögren's Syndrome

Source check: Source checked. Not independent scientific confirmation.

Finding / tested result: The primary full text supports the case-specific result: Machine-learning-selected IFI44 is linked to Sjogren biomarkers and clinical traits with diagnostic validation.

Technology: Machine-learning-selected IFI44 is linked to Sjogren biomarkers and clinical traits with diagnostic validation.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Machine-learning-selected IFI44 is linked to Sjogren biomarkers and clinical traits with diagnostic validation.
Limitation / still unknown
The result is limited to the reported dataset, experimental setting and validation in this study; broader generalization and real-world benefit are not established.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC11366250/ · https://pubmed.ncbi.nlm.nih.gov/39219820/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.